BioSpace News Archive

Therap is being used by a growing number of regional centers in California to submit Special Incident Reports (SIR) through its incident management and general event report (GER) module.

Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share of its common stock, payable on October 25, 2019 to holders of record on September 27, 2019.

Each year GRESB assesses and benchmarks the environmental, social and governance (ESG) performance of real assets worldwide and monitors progress towards global sustainability goals.

Bioasis Technologies, Inc. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need,

MedtechWomen today announced that Lisa Earnhardt, executive vice president, medical devices, at Abbott, has been named the recipient of the fifth annual Ferolyn Powell Leadership Award at the organization’s MedtechVision 2019 conference.

Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that management will participate in the Sidoti & Company Fall 2019 Investor Conference in New York, NY on Wednesday, September 25, 2019.

HemoSonics is excited to announce that its new QStat Cartridge, an extension of its groundbreaking Quantra Hemostasis System, has registered for CE Mark and is now commercially available in Europe and Hong Kong. T

AbbVie and Allergan entered into a definitive transaction agreement pursuant to which AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity value of approximately $63 billion, based on the closing price of AbbVie’s common stock of $78.45 on June 24, 2019.

As the national debate over addressing “surprise billing” of patients continues to unfold, the American Academy of Actuaries is offering an objective actuarial perspective on the financial consequences and considerations involved in proposed public policy solutions to the problem in a new issue brief.

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $850 million aggregate principal amount of 3.300% Senior Notes due 2029 at an issue price of 99.670% of the principal amount.